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In Brief
In the present study, Trulley et al. identify
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stress-activated protein kinase MK2 that
constitutively arises from alternative
translation initiation within the known
MK2 mRNA. The long isoform has unique
and shared molecular properties,
compared to the canonical short isoform.
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https://doi.org/10.1016/j.celrep.2019.05.024SUMMARY
Alternative translation is an important mechanism of
post-transcriptional gene regulation leading to the
expression of different protein isoforms originating
from the same mRNA. Here, we describe an abun-
dant long isoform of the stress/p38MAPK-activated
protein kinase MK2. This isoform is constitutively
translated from an alternative CUG translation initia-
tion start site located in the 50 UTR of its mRNA. The
RNA helicase eIF4A1 is needed to ensure translation
of the long and the known short isoforms of MK2, of
which the molecular properties were determined.
Only the short isoform phosphorylated Hsp27 in vivo,
supported migration and stress-induced immediate
early gene (IEG) expression. Interaction profiling re-
vealed short-isoform-specific binding partners that
were associated with migration. In contrast, the
long isoform contains at least one additional phos-
phorylatable serine in its unique N terminus. In sum,
our data reveal a longer isoform of MK2 with distinct
physiological properties.INTRODUCTION
Post-transcriptional gene regulation (PTGR) constitutes an
important toolbox used to shape gene expression upon intra-
and extracellular cues. PTGR impacts on mRNA processing,
localization, export, stability, and translation. Canonical transla-
tion of mRNA starts on AUG translation initiation sites (TISs) that
are recognized by ribosomes through scanning of the 50 UTR
leader sequence and is dependent on the cap structure. TheCel
This is an open access article undentire translation initiation mechanism is tightly regulated
(Sonenberg and Hinnebusch, 2009) and can be influenced by
sequences in the 50 UTR-bearing internal ribosomal entry sites
(IRESs), secondary structures, or upstream open reading frames
(uORFs) or by ‘‘leaky scanning’’ of sequences preceding the initi-
ator AUG (Kozak sequence), leading to the usage of alternative
start codons that result in alternative protein isoform translation
(Barbosa et al., 2013; Fritsch et al., 2012; Hinnebusch et al.,
2016). The mechanisms by which ribosomes select non-AUG
codons for translation initiation might rely on auxiliary initiation
factors and RNA helicases such as eIF4A1, eIF2A, or Ddx3
(Guenther et al., 2018; Modelska et al., 2015; Sendoel et al.,
2017; Starck et al., 2012; Wolfe et al., 2014). Translation events
starting at these non-AUG start codons have led to the determi-
nation of alternative translation initiation sites (aTISs) (Wan and
Qian, 2014;Wegrzyn et al., 2008). Taken together, these features
of translation explain, in part, how proteome diversity in cells can
be generated from a limited number of transcripts.
Protein kinases and associated signal transduction pathways
play an important role in regulating transcriptional and post-tran-
scriptional events. A well-characterized pathway is the p38MAPK-
MK2-signaling module. The p38MAPK-activated protein kinase
MK2 (or MAPKAPK2) phosphorylates substrates such as the
RNA-binding protein and PTGR master regulator tristetraprolin
(TTP) and the transcription factor serum response factor (SRF)
(Menon and Gaestel, 2018). Numerous reports characterize the
diverse functions of MK2 in inflammation and stress signaling
(Gaestel, 2013), also suggesting its role as a checkpoint kinase
in cancer (Reinhardt et al., 2011). Powerful tools for these studies
are the MK2 knockout (MK2 KO) (Kotlyarov et al., 1999) and the
MK2/3 double knockout (MK2/3 DKO) (Ronkina et al., 2007)
mouse models. Among them, the DKO model seems superior
over the single KO, as it eliminates compensatory effects of
the MK2-related kinase MK3 on MK2 functions (Ronkina et al.,l Reports 27, 2859–2870, June 4, 2019 ª 2019 The Author(s). 2859
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Translation of MK2 from an Alternative Start Codon in Its 50 UTR
(A) Expression profiling of MK2 in different murine and human cell lines by western blot.
(B) Expression profiling of MK2 in mouse organs by western blot.
(legend continued on next page)
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2007). MK2 deletion phenotypes range from defects in immedi-
ate early gene responses over impaired cytokine production and
regulation of apoptosis and/or necroptosis to non-coding RNA
regulation and defects in migration. They could be linked to
specific substrates of MK2, such as TTP (Tiedje et al., 2016)
and SRF (Ronkina et al., 2011), as well as RIPK1 (Dondelinger
et al., 2017; Jaco et al., 2017; Menon et al., 2017), RBM7 (Blasius
et al., 2014; Tiedje et al., 2015), and Hsp25/27 (Hoffman et al.,
2017).
Western blot detection of endogenous MK2 often gave two
bands where only the lower band represented the apparent
molecular mass of the protein kinase (Cano et al., 1996; Stokoe
et al., 1992). Interestingly, ectopically expressed MK2 does not
display the second, slower migrating band. To date, no informa-
tion about the nature of this MK2 isoform expression is available.
We now show that the long MK2 isoform constitutively arises
from alternative translation of an in-frame upstream CUG
alternative translation initiation site in the highly conserved GC-
rich 50 UTR and characterize the properties of this isoform.
RESULTS
Translation of MK2 from an Alternative Start Codon in
the 50 UTR of Its mRNA
MK2 is ubiquitously expressed (Gaestel, 2013), and when
analyzing its expression in different cell lines or in mouse tissues
by western blotting, a multiple band pattern is detected (Figures
1A, 1B, and S1). Of note, the ratio of expression of these bands
varies between tissues and cell lines. In murine cells and tissues,
two predominant bands can be detected in western blot analysis
by using an anti-MK2 antibody directed toward the C terminus of
human MK2 (Figures 1A and 1B). The low-molecular-weight
band corresponds to the hitherto known open reading frame
(ORF) of the gene, whereas the origin and function of the slower
migrating band are obscure, and only one transcript existed in
the NCBI database (NCBI: NM_008551.2). Importantly, both
bands were found to be absent in cells from MK2 KO (described
in Kotlyarov et al., 1999) and MK2/3 DKO mice (described
in Ronkina et al., 2007) (Figures 1A and S1A). In human cell lines,
two dominating bands of around 55 kDa, together with two less
intense bands at around 65 kDa, were detected (Figures 1A,
S1C, and S1D). Two similar human MK2 transcripts (GenBank:
NM_004759.4 and NM_032960.3) can be found in the database
and arise from alternative splicing. Short hairpin RNA (shRNA)-
mediated knockdown of human MK2 in HT29 cells removed all
of these bands, confirming that they were derived from the
same gene (Figure S1D). For the murine MK2-related protein
kinase MK3, only one specific protein product is detected that(C) Genomic tracks of RNASeq and RiboSeq datasets (GEO: GSE81250) for th
version, NM_008551.2. The positions of potential alternative translation initiation
(D) The murine MK2 50 UTR nucleotide sequence and its putative extended in-fra
are marked in bold and italics within both sequences.
(E) Purification of endogenous MK2 isoforms from RAW264.7 cells. Endogenou
flowthrough, and precipitates were separated by SDS-PAGE. Bands were excis
(F) Identification of MK2 peptides from mass spectrometry. The three translation
peptides, and black sequences depict non-detected ones.
See also Figures S1, S2, S3, and S4.is absent in MK2/3 DKO cells (Figures S1A and S1B). From these
data, we concluded that the different MK2 protein bands could
be assigned to distinct protein isoforms that may originate
from different post-translational modifications of MK2, alterna-
tive splicing, or alternative translation events.
To test the hypothesis of the existence of alternative transla-
tion products, we exploited existing RNA-sequencing (RNA-
seq) and ribosome-footprinting (RiboSeq) data from different
cell lines. Initially, data from murine bone-marrow-derived mac-
rophages (BMDMs) (Tiedje et al., 2016) were reanalyzed and
revealed the existence of an MK2 transcript with an extended
50 UTR that also contained several ribosome footprints (RFPs)
within this region (Figure 1C). This supported the idea of the ex-
istence of alternative translation events in the 50 UTR of mouse
MK2. In fact, an MK2 transcript that corresponded to the tran-
script length we detected by RNA-seq was recently deposited
at NCBI (NCBI: NM_008551.2) and replaced the previously an-
notated transcript having only a very short, 18-nt 50 UTR
(NCBI: NM_008551.1; Figure 1C). The analysis of this transcript
showed a potential in-frame extension of the hitherto known
MK2 ORF in the upstream direction (Figure 1D). Within this
extension, we found two putative alternative translation initiation
sites at positions 141 and 309, coding for leucine (CUG) and
valine (GUG), respectively. The CUG and GUG are surrounded
by the alternative Kozak sequences GCCGAGCCUGGAG and
GCAGCCTGUGACG (Wegrzyn et al., 2008). Consistent with
the western blot results, RFPs and sequence analyses revealed
an in-frame extension in the 50 UTR of the human MK2 transcript
bearing the two alternative start codons CUG and GUG (Figures
S2A and S2B). Interestingly, in the human transcript, the CUG is
almost the same distance from the AUG (144 bp, 48 aa) as in
the mouse transcript. Overall, more than 80% sequence identity
within the first 200 bp upstream of the start AUG codon exists
between the murine and human 50 UTRs (Figure S2C). Further
sequence analyses showed that the 50 UTR extension is evolu-
tionary conserved among species, indicating a distant origin
for alternative translation of MK2 isoforms (Data S1). This obser-
vation was supported by analyzing published RiboSeq datasets
of murine and human cells that were treated with cycloheximide,
harringtonine, or lactimidomycin before sequencing of ribo-
some-protected mRNA fragments (Fields et al., 2015; Fijalkow-
ska et al., 2017; Gawron et al., 2016; Ingolia et al., 2012; Oh
et al., 2016; Sendoel et al., 2017; Valentin-Vega et al., 2016).
Since mRNA-bound ribosomes are frozen at translation initiation
start sites by these treatments, as previously exemplified in
pioneering RiboSeq studies (Ingolia et al., 2011; Lee et al.,
2012), the existence of footprints in the 50 UTR of MK2 strongly
argues for alternative translation events. Indeed, we coulde old MK2 transcript NM_008551.1 and its most recent annotated transcript
sites (aTISs) within the 50 UTR and the AUG initiation sites are marked.
me N-terminal amino-acid sequence. The alternative translation initiation sites
s MK2 was purified from 1 3 108 RAW264.7 cells using a MK2-Trap. Lysate,
ed for mass spectrometry.
initiation sites are marked in bold and italics. Red sequences depict detected
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observe such footprints in murine and human cell lines in the 50
UTR of MK2 (Figures S3 and S4).
To validate the existence of an N-terminal extended MK2, we
purified endogenous MK2 from murine RAW264.7 cells that ex-
press almost equal levels of both MK2 isoforms (Figures 1A and
1E). By using aMK2-Nanotrap, we were able to enrich and purify
considerable amounts of endogenous MK2 from these cells and
subsequently analyzed them by mass spectrometry (Figures 1E
and 1F). We readily identified peptides derived from the pre-
dicted in-frame 50 UTR extension originating from the CUG alter-
native translation initiation sites at position141 (Figure 1F). The
detection of peptides derived from sequences further upstream
of this CUG indicates that the GUG in position 309 or other co-
dons may also be used for alternative translation initiation. In
sum, these results confirmed the existence of at least one alter-
native translation initiation site at position 141 in the 50 UTR of
the MK2 transcript, resulting in the translation of a minimum of
two distinct MK2 isoforms in murine and human cells from the
same mRNA.
Mechanistic Insights into Regulation ofMK2 Translation
To further characterize the usage of the putative alternative
translation initiation site at position 141 of MK2 mRNA, we
fused the extended endogenous murine 50 UTR with the known
murine MK2 ORF and expressed the construct in different cell
lines. The high GC content of the 50 UTR (>85%) prompted us
to introduce a synthetic DNA flanked by restriction sites (Fig-
ure S5A). Expression of the 50 UTR-MK2-ORF construct resulted
in the two-band pattern known for endogenousmurineMK2 (Fig-
ures 2A, S5B, and S5C). Mutagenesis of the putative alternative
translation initiation sites at positions 141 and 309 resulted
in an altered band pattern and revealed that the triplet CUG
at 141 is used for alternative translation initiation under these
conditions, leading to expression of the long isoform (Figure 2A,
lane 5). Nonetheless, the CUG is a much weaker initiation site
than AUG (Figures 2A; compare lanes 2, 3, and 4). Disrupting
the alternative Kozak sequence surrounding the CUG (adjacent
GAG to CAU) impaired the expression of the long isoform (Fig-
ure 2A, lane 6). Interestingly, it was even possible to generate a
super-long MK2 isoform by mutating 309 GUG to AUG (Fig-
ure 2A, lane 7).
Next, we explored the underlyingmolecular mechanism allow-
ing MK2 isoform translation in vivo. Human cells treated with the
anti-cancer drug silvestrol (also known as rocaglamide) respond
with a decrease in the translation of a selective set of mRNAs due
to inhibition of the RNA helicase eIF4A1 (Modelska et al., 2015;
Wolfe et al., 2014). Among them, MK2 mRNA is a major target
(Wolfe et al., 2014). Additionally, it was suggested that mRNAs
commonly regulated by this mechanism contain long and
GC-rich 50 UTRs with potential G-rich quadruplex structures
(Modelska et al., 2015; Wolfe et al., 2014). In turn, recent data
show that eIF4A1 is rather clamped to purine-rich, motif-contain-
ing transcripts by rocaglamide, inhibiting their translation and
questioning the requirement of eIF4A1 in G-rich quadruplex
structure resolution (Iwasaki et al., 2016; Iwasaki et al., 2019).
Furthermore, it was shown that eIF4A1 targets preferentially
mRNAs with 50 UTRs containing classical secondary structures
rather than G-quadruplexes (Waldron et al., 2018). Nonetheless,2862 Cell Reports 27, 2859–2870, June 4, 2019and due to the high GC content of MK2’s 50 UTR, wewere able to
detect computationally predicted sequences (Kikin et al., 2006)
that could give rise to G-rich quadruplex structures located up-
stream of the alternative translation initiation site CUG and the
AUG within the 50 UTR of human and murine MK2 (Table S1). In-
dependent of the existence of these structures, we speculated
that the helicase eIF4A1 might play a role in general or selective
MK2 isoform translation. As seen, upon depletion of eIF4A1, a
marked decrease in translation of both MK2 isoforms in murine
cells and, at least, a decrease of the short isoform in human cells
were observed (Figures 2B and S6A). It was proposed that the
translation initiation auxiliary factor eIF2A is important for non-
AUG translation initiation (summarized in Kearse and Wilusz,
2017) and expression of the PTEN isoform PTEN-alpha has
been described to be dependent on this factor and a surrounding
palindromic sequence (Hopkins et al., 2013; Liang et al., 2014).
However, we only observed non-selective moderate effects of
eIF2A depletion on MK2 translation in murine cells (Figure 2B).
In contrast to the literature, we detected a stronger dependence
of the PTEN/PTEN-alpha translation on eIF4A1, as small
interfering RNA (siRNA)-mediated depletion of eIF2A interfered
with eIF4A1 downregulation (Figure 2B, lane 3). Possibly due to
insufficient siRNA-mediated depletion, we could not detect any
effects of eIF2A on human PTEN/PTEN-alpha level (Figure S6A).
We then re-analyzed the mouse organs (Figure 1B) for eIF4A1
expression (Figure 2C). Higher eIF4A1 levels principally corre-
lated with higher levels of both MK2 isoforms, but it remains
too tempting to postulate a final conclusion at this stage.
Epigenetic markers of mRNAs, such as m6-adenosine methyl-
ation, influence the stability and translation of modified mRNAs
(Fu et al., 2014). Human MK2 mRNA is heavily methylated near
the stop codon, and translation of MK2 mRNA was reported to
be strongly decreased upon depletion of the methyltransferase
METTL3 (Lin et al., 2016; Wang et al., 2015). However, we could
only observe a moderate decrease of MK2 protein in HEK293T,
which was accompanied by a known METTL3-dependent
decrease in SRF protein level (M€uller et al., 2018) (Figure S6B).
We were not able to get conclusive results from Mettl3 knock-
down experiments in murine cells and do not know whether
murine MK2 mRNA undergoes methylation in vivo (Figure S6B).
To additionally prove a role for the GC-rich sequences in MK2
isoform translation, we generated a set of MK2 reporter mutants
that were intended to recapitulate the requirement of these
sequences for the translation of the long alternative MK2 isoform
(Figure 2D, left): compared to the 50 UTR full-length construct (1),
the sequences upstream of the alternative translation initiation
site CUG were either completely truncated (2) or replaced by
an unstructured short beta-globin stretch (3), a combination of
beta-globin with scrambled GC-rich sequences (4), or beta-
globin fused to GC-rich sequences known to form three-layered
G-quadruplex sequences and known to inhibit translation (5).
Clearly, the loss of CUG upstream sequences abrogated
translation of the long MK2 isoform, as compared to the full-
length construct (Figure 2D, lanes 1 and 2). Stepwise rescue of
GC-rich sequences enhances long isoform translation (Fig-
ure 2D, lanes 3 and 4), whereas true G-rich quadruplexes
inhibited markedly long and importantly also short isoform trans-
lation (Figure 2D, lane 5). This supported the notion that GC-rich
AC D
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Figure 2. Mechanistic Insights into Regulation of MK2 Translation
(A) Expression of murine MK2 50 UTR isoforms in U2OS cells through the introduction of 50 UTR point mutations (see Figure S5A). Lysates were analyzed by
western blot with an anti-MK2 antibody and an anti-p150 antibody as loading controls. Arrows indicate the different MK2 isoforms. The resulting schematic
representation of codon usage and their consequent translation into the short and long MK2 isoforms is shown below.
(B) RAW264.7 cells were transfected with siRNAs targeting eIF4A1 or eIF2A. Lysates were analyzed for eIF4A1 and eIF2A levels to monitor knockdown efficacy
andMK2 and PTEN to detect consequences of the knockdowns. p150was used to normalize the signals for quantification. Three biological replicates (n = 3) were
performed and used for quantifications of the signals (except for the double knockdown of eIF4A1 and eIF2A [n = 1]) and are shown as means ± SD. Arrows
indicate PTEN and its longer isoform PTEN-alpha. *p% 0.05; **p% 0.01; ***p# 0.001; ****p% 0.0001.
(C) Reanalysis of the mouse organ lysates from Figure 1B to test for eIF4A1 expression. Loading control: eEF2.
(D) Schematic representation of MK2 reporter constructs (1–5) to analyze the role of GC-rich sequences in CUG usage (left). b-G, beta-globin; scr., scrambledGC
rich; GQ3, three-layered G-rich quadruplex. The asterisk indicates the endogenous short MK2 isoform from U2OS cells. p150 was used as loading control.
See also Figures S5 and S6 and Table S1.sequences forming classical secondary structures rather than
G-rich quadruplexes promote translation of the long MK2
isoform. In summary, we demonstrate a major role for the RNA
helicase eIF4A1 in the translation of distinct MK2 isoforms and
suggest that GC-rich sequences upstream of the alternative
translation initiation site CUG support long isoform translation
from a single mRNA species (Figure S6C).
Functional Characterization of MK2 Isoforms
To address the physiological consequences of MK2 isoform
expression, we stably reconstituted MK2-deficient mouse
embryonic fibroblast (MEF) cell lines (Ronkina et al., 2007) withthe short, the long, or both isoforms of MK2 expressed to similar
levels, as compared to endogenous MK2 in RAW264.7 and
HEK293T cells (Figure 3A). Interestingly, when using the super-
long isoform for rescuing the MK2-deficient MEFs (Figure S7A),
we lost the expression of all other MK2 isoforms observed in
transient transfection experiments (cf. Figures 2A, S5B, and
S5C). First, we assessed the relative stability of the twoMK2 iso-
forms after a cycloheximide-induced block of de novo protein
translation in the rescued cells in comparison to the endogenous
isoforms in RAW264.7 and HEK293T cells (Figures 3B, 3C
and S7B). As seen, the longer variant was considerably more
stable than the short isoform in these assays. Nuclear cytosolicCell Reports 27, 2859–2870, June 4, 2019 2863
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Figure 3. Functional Characterization of MK2 Isoforms
(A) Complementation of MK2/3 DKOmouse embryonic fibroblasts (MEFs) by retroviral transduction with MK2 constructs derived from Figure 2A. Empty-vector-
transduced cells served as controls. Isoform expression levels are compared to the expression of endogenous MK2 isoforms in RAW264.7 and HEK293T cells.
(legend continued on next page)
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shuttling of MK2 triggered by activated p38MAPK is a hallmark of
MK2 activation (summarized in Gaestel, 2006). We, therefore,
compared the localization of both isoforms in non-stressed cells,
and, when we activated p38MAPK by different stresses, their
redistribution over time to the cytosol (Figures 3D and S7C).
Regardless of the stress conditions, no substantial differences
of the isoforms in shuttling from the nucleus to cytosol were
observed.Monitoring the redistribution of the super-long isoform
was not possible, since transfection of this construct was
accompanied by short and long isoform expression (Figure S7D).
We then tested the ability of the isoforms in cells to phosphory-
late the known MK2 substrates Ube2j1, SRF, RIPK1, Reticulon
4B/NOGO-B, and Hsp27 (also HSBP1 or Hsp25 in mice) upon
activation by anisomycin in a p38MAPK-dependent manner (Fig-
ure 3E). The specificity of phosphorylation was assessed with
chemical inhibitors against MK2’s upstream kinase p38MAPK
(p38i) and MK2 itself (MK2i) (Figure 3E). In accordance with pre-
vious reports (Ronkina et al., 2007), we also detected reduced
total p38MAPK level in MK2/3 double-deficient cells (see empty
vector (EV)-transduced cells). While substrates were readily
phosphorylated by both isoforms, phosphorylation of the small
heat shock protein Hsp27, a bona fide substrate of MK2, could
only be detected for the short MK2 isoform (Figure 3E). This
finding indicated the intriguing possibility that both isoforms
differed in their substrate specificity in vivo. To further test this,
we performed an in vitro kinase assays using purified MK2
isoforms from rescued MEFs and recombinant murine Hsp25
(Figures 3F and S7E). We could not confirm the inability of the
long MK2 isoform to phosphorylate Hsp25 under these condi-
tions, indicating the existence of a ternary factor, which inhibits
long MK2-Hsp27 interaction in vivo. Taken together, we were
able to reconstitute MK2-deficient cells with individual isoforms.
Both murine isoforms of MK2 share molecular properties, such
as the ability to translocate from the nucleus to the cytoplasm,
but differ in their stability and probably in their substrate speci-
ficity in vivo.
Phenotypical Consequences ofMK2 IsoformExpression
Expression of both isoforms differs among mouse tissues
(Figure 1B). Therefore, we speculated on physiologically relevant(B) The stability of MK2 isoforms in RAW264.7 cells was analyzed after cyclohexim
normalize MK2 signals. Three independent biological replicates (n = 3) were analy
The blots show representative results of one replicate.
(C) The stability ofMK2 isoforms inMK2/3 DKO complementedMEFswas analyze
loading control was used to normalize MK2 signals. Three independent biological
shown for each time point. The blots show a representative result of one replica
(D) Fluorescence microscopy to determine the percentage of nuclear and cytoso
three independent biological replicates (n = 3) ± SD. For each replicate, a minimum
a negative control. *p% 0.05 (unpaired t test).
(E) Complemented MK2/3 DKO MEFs were analyzed for MK2 substrate p
(pp38T180/Y182) and MK2 (pMK2T334) itself was used as a readout for activation o
ylations, cells were either pre-incubated with a p38MAPK inhibitor (p38i) or an MK
Ube2j1 protein shifts (indicated by arrows) were used as readouts.
(F) Semi in vitro non-radioactive kinase assay. MK2 isoforms were purified from
recombinant murine Hsp25 in the presence of ATP. Phosphorylation of Hsp25 wa
phospho-specific anti-pMK2T334 was used to monitor MK2 activation. Specificity
membrane showed equal presence of recombinant murine Hsp25 in all samples
See also Figure S7.differences and attempted to explore the phenotypical conse-
quences of isoform expression in MK2/3-deficient MEFs. We
initially tested proliferation of the differently rescued cell lines
(Figure S8A). Cells grew to a similar extent independently of
the isoform used for rescue. We then checked the induction of
the immediate early genes (IEGs) early growth response 1
(Egr1), FBJ osteosarcoma oncogene (cFos), and TTP (or Zfp36)
upon anisomycin stimulation of MK2/3-deficient MEFs rescued
with the different isoforms of MK2 (Figure 4A). While expression
of the short isoform elevated the expression of all of these genes,
the long isoform of MK2was not able to induce IEGs. Of note, we
were not able to detect differences in SRF phosphorylation by
the isoforms (Figure 3E), indicating that other MK2-dependent
mechanisms regulate IEG transcription under these conditions.
Since it is known that the N terminus of MK2 plays an important
role in cell motility (Kotlyarov et al., 2002), we also assayed for
cell migration using a scratch assay (Figure 4B). As seen, the
migration phenotype could only be rescued by the short MK2
isoform, consistent with our observation that only the short
isoform of MK2 is competent for phosphorylation of the migra-
tion-associated substrate Hsp27 (Figure 3E). Collectively, these
results highlighted differential functional properties of MK2
isoforms.
MK2 Isoform Interaction Profiling
The phenotypic differences in our rescue cell lines suggested
that the two MK2 isoforms could have overlapping and unique
interaction partners. As a control for the proficiency of both pro-
teins, we first precipitated the isoforms with MK2-Trap beads
and confirmed their well-characterized interaction with the up-
stream activating kinase p38MAPK (Figure S8B). We then used
quantitative mass spectrometry to analyze the interaction part-
ners of both isoforms in cells that were left untreated or treated
with combinations of anisomycin and the MK2 inhibitor (MK2i)
PF-3644022. This approach allowed us to compare MK2 activ-
ity-dependent interaction partners of the two MK2 isoforms.
While we detected only a few isoform-specific interactions in
resting cells (i.e., Polr1b for the long isoform), stress induction
by anisomycin, especially in combination with the MK2 inhibitor,
revealed a strong bias toward the short MK2 isoform foride (CHX) chase for the indicated times. The p150 loading control was used to
zed for each sample, and the mean of them ± SD is shown for each time point.
d after chasing cells with cycloheximide (CHX) for the indicated times. The p150
replicates (n = 3) were analyzed for each sample, and the mean of them ± SD is
te.
lic MK2 after treatment with p38MAPK activators. The results show the mean of
of 100 cells were counted. Cells incubated with a p38 inhibitor (p38i) served as
hosphorylation upon anisomycin stimulation. Phosphorylation of p38MAPK
f the pathway. To control activity and selectivity of MK2 substrate phosphor-
2 inhibitor (MK2i). Loading control: p150. In the case of RIPK1, NOGO-B and
MEFs after the indicated treatments. Precipitates were incubated with 600 ng
s tested by western blot using a phospho-specific anti-pHsp27S82 antibody. A
was confirmed by the p38MAPK inhibitor (p38i) samples. Ponceau staining of the
.
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AB
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Figure 4. Consequences of MK2 Isoform Expression
(A) Analysis of TTP, cFos, and Egr1 expression upon anisomycin stimulation in rescued MEFs. Each data point represents a biological replicate that was
measured in duplicates. Error bars represent themean of three independent replicates (n = 3) ±SD. The p valueswere retrieved from unpaired t tests using PRISM
8 software and are related to GFP/EV-rescued MEFs. *p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001.
(legend continued on next page)
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interaction with proteins of the myosin family (Myh1, Myh4,
Myh8, Myl1, Myl12a, and and Mylpf) and the transcriptional ma-
chinery (Med23 and Cnot10) (Figure 4C; Data S2). Gene
Ontology (GO) term analysis (Figure S8C) revealed proteins,
such as Arpc2 or Ddx58, to interact with the short MK2 isoform
(Figure 4C), connecting it to the cytoskeleton via actin or the
myosin machinery. Given the fact that MK2-dependent migra-
tion is only rescued by the short isoform, which is also uniquely
capable of phosphorylatingHsp27upon stress in vivo (Figure 3E),
we speculate that these short-isoform-specific interactions un-
derlie the migration of MK2-proficient cells. In line with our
biochemical experiment (Figure 3E), our proteomics analysis
confirmed that both MK2 isoforms readily interact with
p38alpha/beta (Mapk11/14) in a stimulus-independent manner
(Figure 4C; Figure S8B). Furthermore, we were able to confirm
the interaction of the long isoform with Polr1b under resting con-
ditions (Figure S8D). Surprisingly, we were not able to detect this
interaction when both isoforms were co-expressed (Figure S8D).
Attempts to validate specific interaction of the short isoform with
proteins of the myosin family by western blot failed due to the
lack of specific antibodies.
When we strongly overexpressed MK2 in HEK293T or HeLa
cells, we detected a double-band pattern of the long isoform
indicating, e.g., phosphorylation events in the extended N termi-
nus of long MK2 (cf. Figures S5B and S5C). Consequently, the
upper of the two bands disappeared when treating lysates with
lambda-phosphatase (Figure 4D). Importantly, the double-
band pattern was not a result of stress-induced MK2 phosphor-
ylation (Figure 4D). Since we enriched the MK2 isoforms for our
interaction profiling approach, it was possible to detect unique
long-isoform-specific, proline-directed serine and threonine
phosphorylation sites in the extended N terminus in the mass
spectrometry analysis (Figure 4E). Introducing point mutations
in the extended N terminus revealed serine 36, relative to the
canonical initiating methionine, to be constitutively phosphory-
lated, as its mutation to alanine resulted in an almost complete
loss of the double-band pattern without changing the phosphor-
ylation status of MK2 at the known T334 site (T320 in mouse)
(Figure 4F). Re-analyzing the same type of samples on a Phos-
tag gel confirmed this observation (Figure 4G) and supported
the idea of an additional constitutive serine phosphorylation in
the unique N terminus of long MK2. Attempts to identify the ki-
nase targeting this site in vivo were difficult, as the target site
seems not be stress regulated, and the sequences surrounding
serine-36 display no classical proline-directed motif.(B) Fluorescence-based scratch wound healing assay for rescued MEFs. Each ind
replicates is shown ± SD. The p values were retrieved from an ordinary one-way A
MEFs. *p% 0.05; ****p% 0.0001.
(C) Volcano plots of significantly short- and long-isoform-interacting proteins at th
define the border of significantly interacting proteins. Significance was calculate
(D) Transfection of HEK293T cells with a 50 UTR-MK2 wild-type construct. Sampl
western blots. Blotting for phosphorylated MK2 (pMK2T334) served as dephosph
(E) Schematic representation of long-isoform-specific unique phosphorylated res
in red with a star and are numbered in relation to the initiating methionine of the
(F) Expression of 50 UTR-MK2 wild-type or S-36A-50 UTR-MK2 mutant in HEK29
NOGO-B served as controls for activation by anisomycin. Loading control: p150
(G) The indicated samples from transfected HEK293T cells were analyzed with a
See also Figure S8.Taken together, these results revealed that the two MK2 iso-
forms have both common and distinct interaction partners. The
specific interactions of the short isoform with migration-associ-
ated proteins and transcriptional regulators may explain why
some MK2-dependent phenotypes are only rescued by this
MK2 variant. On the other hand, the unique N terminus of the
long isoform displays at least one serine that is constitutively
phosphorylated by a yet-unidentified kinase.
DISCUSSION
AnN-terminal extended long isoform of the protein kinaseMK2 is
constitutively translated from an in-frame CUG alternative trans-
lation initiation site upstream of the known AUG initiation codon.
The constitutive usage of this alternative translation initiation site
was confirmed by mutational studies and analyses of ribosome
footprinting data. These findings were supported by the detec-
tion of endogenous peptides by mass spectrometry.
Two reports identified MK2 as a target of the RNA helicase
eIF4A1 (Modelska et al., 2015; Wolfe et al., 2014). Our data
show that eIF4A1 regulates MK2 translation of both isoforms.
By using MK2 50 UTR reporter constructs, we could exclude
that the usage of CUG is supported by potential surrounding
G-quadruplex structures that are usually known to negatively
regulate translation (Bugaut and Balasubramanian, 2012). In
turn, rather classical, secondary structured GC-rich sequences
sensitive to eIF4A1 (Waldron et al., 2018) upstream of the CUG
support its usage as an initiation site. The data suggested that
the scanning mechanism of the ribosome is slowed down, and,
consequently, a leaky scanning leads to the usage of the CUG
for translation initiation. This mechanism appears evolutionarily
conserved, yet murine cells produce relatively more of the long
and alternative isoforms compared to their human counterparts.
This correlates with the fact that the human 50 UTR is shorter than
that of the murine counterpart and that the GC-rich sequences
surrounding the CUG are shorter.
Examples of in-frame N-terminal protein extensions origi-
nating from alternative translation starting in the 50 UTR have pre-
viously been described, i.e., for PTEN (Hopkins et al., 2013; Liang
et al., 2014) or thioredoxin/glutathione (Gerashchenko et al.,
2010). It was suggested that eIF2A is a specificity factor for
non-AUG translation initiation (summarized in Kearse and Wi-
lusz, 2017). To this end, we only observed moderate effects of
eIF2A on MK2 translation. It also remains to be clarified whether
the RNA helicase Ddx3 (Guenther et al., 2018) is a regulatoryividual data point represents a biological replicate (nR 19), and the mean of all
NOVA using PRISM 8 software and are related to EV-transducedMK2-deficient
e indicated conditions. Selected proteins are highlighted in red. The black lines
d in MaxQuant.
es were treated as indicated and analyzed for phosphatase-sensitive bands by
orylation control (right). Loading control: p150.
idues within the extended N terminus. Phosphorylated residues are highlighted
canonical MK2 ORF.
3T cells. Treatment as indicated. Blots against phosphorylated p38MAPK and
.
Phos-tag gel.
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factor for MK2 isoform translation alone or in cooperation with
eIF4A (Gao et al., 2016).
The long MK2 isoform identified here behaves in a manner
identical to that of the canonical protein in terms of activation
by and interaction with the upstream kinase p38MAPK. On the
other side, the long MK2 isoform had a decreased turnover
rate as compared to its short counterpart, displayed a unique
additional serine phosphorylation site in its extended N terminus,
and failed to phosphorylate the MK2 bona fide substrate Hsp27
upon anisomycin stimulation in vivo (summarized in Figure S8E).
This is similar to the different p38MAPK isoforms, which exhibit
distinct substrate specificities although displaying a high degree
of amino-acid sequence identity (Cuenda and Rousseau, 2007).
In an MK2-deficient background, only expression of the short
MK2 isoform or both isoforms can rescue migration and IEG de-
fects. As revealed by mass spectrometry, the preferred binding
of the short MK2 isoform to proteins of the cytoskeleton and
the transcription machinery correlates with the unique ability of
this isoform to rescue migration and transcriptional defects.
Both processes are well-established MK2-dependent re-
sponses (Menon et al., 2009; Ronkina et al., 2011). The long
isoform of MK2 is likely to have exclusive functions as well.
The unique N-terminal extension of this protein contains putative
proline-directed serine and threonine phosphorylation sites. We
could determine S-36 to be constitutively phosphorylated by a
yet-unidentified kinase. Interestingly, the phosphorylation of
this site is not induced by stress activation. We, therefore, spec-
ulate that this site is targeted by other proline-directed kinases
than p38MAPK, such as cyclin-dependent kinases (CDKs) (Ma-
lumbres, 2014). Isoform-specific modifications could potentially
allow for the recruitment of unique substrates and the assign-
ment of unique functions of the long MK2 isoform and clearly
warrant future investigation. We can only speculate on the con-
sequences of this phosphorylation, but we want to stress that
expression of the short isoform alone was often accompanied
by a ‘‘super-rescue’’ of MK2 deficiency, compared to the rescue
by expression of both isoforms together (see Figures 4A and 4B).
Furthermore, using IUPred2A (Me´sza´ros et al., 2018) showed
that the extendedN terminus is entirely disordered. Nonetheless,
the long isoform failed to localize to stress granules or P-bodies
(data not shown).
Future phospho-proteomic studies could shed additional light
on the substrate specificities of the two MK2 isoforms and their
relevance in vivo. Our work reveals the abundant translation of a
hitherto unrecognized MK2 isoform with unique functional prop-
erties, highlighting that the biology of this kinase is still not fully
understood. Our work also resolves a long-standing mystery
surrounding the presence of the additional high-molecular-
weight MK2 band (Cano et al., 1996; Ronkina et al., 2007; Stokoe
et al., 1992).STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
The following cell lines were primarily used in this study: Human osteosarcoma cells (U2OS), human embryonic kidney (HEK293T)
cells, murine RAW264.7 cells and MK2/3 double-deficient mouse embryonic fibroblasts (MEFs), that were retrovirally rescued
with different MK2 constructs. They were all cultured in DMEM medium supplemented with 10% fetal bovine serum, L-glutamine,
penicillin and streptomycin at 37C in a humidified incubator containing 5% CO2. The cells were either obtained from ATTC or in
case of the MEFs generated previously.
Handling of wild-type, MK2 knockout and MK2/3 double knockout mice (all C57BL/6J background) complied with all relevant
ethical regulations and was approved by the ethics committee of the Hannover Medical School. Mice were bred and maintained
at the mouse facility of the Hannover Medical School. Female mice, not older than six weeks, were used in the relevant experiments.
Information on cell lines and mouse strains can be found in the Key Resources Table.
METHOD DETAILS
Tissue culture, cell lines, treatments
Cells were grown on plates in DMEM in the presence of 10% (v/v) FCS, 100 U penicillin G/mL, and 100 mg/mL streptomycin (all
purchased from Life Technologies) in a humidified atmosphere at 37C with 5% CO2 supplementation. Treatments with stimulators
and inhibitors were done with the following final concentrations: Anisomycin, 10 mg/ml, dissolved in DMSO (Sigma); p38 inhibitor
BIRB796, 1 mM, dissolved in DMSO (Axon Medchem); MK2 inhibitor PF3644022 (10 mM, Sigma) dissolved in DMSO; Cycloheximide,
20 mg/ml, dissolved in water, Sigma; Sorbitol (0,5 M, Sigma), dissolved in water; Na-Arsenite (0,5 mM, Sigma) dissolved in water;
IL-1beta (2 ng/ml, Peprotech), dissolved in medium. For gene expression experiments cells were starved in serum-free medium
for a minimum of 8h. MK2-deficient and MK2/3 double-deficient MEFs were described before (Ronkina et al., 2007; Ronkina
et al., 2011). All other standard laboratory cell lines were either kind gifts or obtained from ATCC.
Isolation of mouse organs/bone marrow-derived macrophages
Organs of a wild-type and bone-marrow of wild-type, MK2 KO and MK2/3 DKO animals (C57BL/6J background) (Kotlyarov et al.,
1999; Ronkina et al., 2007) were isolated after sacrificing them. Handling of mice complied with all relevant ethical regulations
andwas approved by the ethics committees of the HannoverMedical School. Organswere flash-frozen in liquid nitrogen before lysis.
To derive macrophages from bone marrow after the femurs of one mouse of each genotype were flushed. Cells were then grown in
the presence of 10 ng/ml M-CSF for approximately 9-10 days before using them for further experiments (Tiedje et al., 2016).
Transfection of cell lines
Cells were seeded the day before transfection to reach 50% density on the next day. The medium was then changed to penicillin/
streptomycin-free. DNA was mixed in Opti-MEM (Life Technologies) and complexed with polyethylenimine (PEI, 1 mg/ml, pH 7.0,
Sigma). After a minimal incubation of 10 min at room temperature the mix was added drop-wise to the cells. Medium was changed
to full medium 6 h and cells were treated 24 h post-transfection and harvested.
For microscopy experiments using U2OS cells transfections were carried out according to the manufacturer using FUGene6
(Promega).
siRNA transfections
All cell lines were transfected using HiPerFect (QIAGEN), RNAiMAX (Thermo Fisher Scientific) or Lipofectamin 2000 (Thermo Fisher
Scientific/Invitrogen) according to the manufacturer’s instruction. The following siRNAs were used:
The sequences of all siRNAs used in this study are listed in Table S2. siRNAs were either synthesized by Eurofins/MWG or
purchased from the indicated supplier.
Generation of stable shRNA knockdown cell lines
Stable HT29 cells were previously described (Menon et al., 2010). In brief, two different lentiviral particles (Mission shRNA lentiviral
particles (Sigma)) and a control lentiviral particle were used. The identifiers of the shRNA particles are specified in Table S2.
After transduction, cells were selected with puromycin (2 mg/mL) for 2 weeks and consequently tested for MK2 expression by West-
ern Blot.
Cloning
A detailed description of the cloning strategy to express MK2 with its full-length 50UTR is shown in Figure S5A. The indicated 441 bp
50UTR-MK2 fragment having NheI and PstI sites was synthesized by GENEART GmbH (Thermo Fisher Scientific). The peGFP-C1-
MK2 and pMMP-MK2-IRES-eGFP constructs for expression in mammalian cells and for retroviral transduction were described
before (Ronkina et al., 2007; Schwermann et al., 2009). Point mutations were inserted by site-directed mutagenesis.Cell Reports 27, 2859–2870.e1–e6, June 4, 2019 e3
SDS-PAGE and Western Blot
If not stated differently proteins were separated on 10%SDS acrylamide gels and transferred to nitrocellulosemembrane by semi-dry
transfer. Phos-tag gels contained 25 mMPhos-tag stock solution (Wako Chemicals) and 0,2 mMMnCl2. Before semi-dry transfer to a
PVDF membrane, gels were washed three times for 30 minutes in 10 mM EDTA-containing transfer buffer. Transfer buffer contained
0,1% SDS and 1 mM EDTA. For Western Blot developments blocking and secondary antibody incubations were done for 1h at room
temperature in 5% dry-milk powder dissolved in PBS containing 0.1% Tween 20 (PBS/T). Primary antibodies were usually incubated
overnight at 4C and diluted in 5% BSA dissolved in PBS/T. Antibodies to detect specific proteins: anti-MK2 (CST, #3042
and #12155), anti-pMK2T222 (CST, #3316), anti-pMK2T334 (CST, #3041), anti-MK3 (CST, #7421), anti-p38 (CST, #8690), anti-
pp38T180/Y182 (CST, #9216), anti-NOGO-B (R+D Systems, AF6034), anti-pHsp27S82 (CST, #9709), anti-GAPDH (EMD Millipore,
#MAB374), anti-Tubulin (Sigma, #T6199), anti-eEF2 (SCBT, sc-13004), anti-p150 (BD Biosciences, #610473), anti-Mettl3 (CST,
#96391), anti-eIF4A1 (CST, #2490), anti-eIF2A (Proteintech, 11233-1-AP), anti-PTEN (CST, #9559), anti-Polr1b (Biorbyt,
orb411900), anti-RIPK (BD Biosciences, #610459), anti-SRF (CST, #5147), anti-pSRFS103 (CST, #4261), anti-Ube2j1(SCBT, sc-
100624) and anti-GFP (SCBT, sc-9996). HRP-coupled secondary antibodies were used for ECL-based detection of proteins on either
a LAS3000 FujiFilm or a Bio-Rad ChemiDoc Imaging System.
Protein dephosphorylation assay
Preparation of lysates was performed in the absence of phosphatase inhibitors and after clearing, the lysates were normalized by
Bradford analysis. Usually 40 ml lysate was treated with 1 ml of lambda-phosphatase (NEB, 400 U/ml) for 30 minutes at 30C in the
presence of MnCl2 (1 mM final) and 1 x PMP buffer (NEB) under constant agitation in an Eppendorf incubator (900 rpm). Reactions
were stopped by adding 2 x SDS sample buffer.
Kinase Assay
For kinase assays MK2 isoforms were purified from one confluent 15 cm plate of the rescued MEF cell lines. For this, an agarose
MK2-Trap binder (Chromotek) was used according to the manufacturer’s protocol. To ensure protein purity without co-purification
of other proteins, precipitates were extensively washed in MK2-Trap dilution buffer and finally resuspended in 40 ml kinase assay
buffer (25 mM HEPES, pH 7.5, 25 mM MgCl2, 2 mM DTT, phosphatase/protease inhibitors and 100 mM ATP). Per reaction 600 ng
recombinant murine Hsp25 (1,25mg/ml, ENZO Life Sciences) were added before incubation them for 30 minutes at 30C in an
Eppendorf incubator under gentle agitation (500 rpm). Reactions were stopped by the addition of 2 x SDS sample buffer and conse-
quent heating for 5minutes at 95C. Samples were then analyzed byWestern Blot developing with a phospho-specific anti-Hsp27S82
antibody. Total, recombinant Hsp25 could be Ponceau-stained for visualization.
MK2 precipitation and LC-MS for the identification of MK2 peptides
Precipitation MK2 was done with the help of an agarose MK2-Trap binder (Chromotek) following the manufacturer’s protocol. After
final washing of the agarose beads, proteins were eluted using 2x SDS loading buffer and incubated for 5min at 95C. Eluted proteins
were then alkylated by addition of acrylamide up to a concentration of 2% and incubation at room temperature for 30 min. Samples
were then separated on a 10% SDS acrylamide gel. After electrophoresis proteins were stained with Coomassie Brilliant Blue (CBB)
for 15 min and background staining was reduced with water. Specific MK2 lanes were excised and minced to 1 mm3 gel pieces.
Further sample processing was done as described (Jochim et al., 2011). Briefly, gel pieces were destained two times with 200 mL
50% acetonitrile (ACN), 50 mM ammonium bicarbonate (ABC) at 37C for 30 min and then dehydrated with 100% ACN. Solvent
was removed in a vacuum centrifuge and 100 mL 10 ng/mL sequencing grade Trypsin (Promega) in 10% ACN, 40 mM ABC were
added. Gels were rehydrated in trypsin solution for 1 hour on ice and then covered with 10% ACN, 40 mM ABC. Digestion was per-
formed overnight at 37C and was stopped by adding 100 mL of 50% ACN, 0,1% trilfluoroacetic acid (TFA). After incubation at 37C
for 1 hour the solution was transferred to a fresh sample vial. This step was repeated twice and extracts were combined and dried in a
vacuum centrifuge. Dried peptide extracts were redissolved in 30 mL 2% ACN, 0.1% TFA with shaking at 800 rpm for 20 min. After
centrifugation at 20,000 x g aliquots of 12.5 mL each were stored at 20C. Peptide samples were separated with a nano-flow
ultra-high pressure liquid chromatography system (RSLC, Thermo Scientific) equipped with a trapping column (3 mm C18 particle,
2 cm length, 75 mm ID, Acclaim PepMap, Thermo Scientific) and a 50 cm long separation column (2 mm C18 particle, 75 mm ID,
Acclaim PepMap, Thermo Scientific). Peptide mixtures were injected, enriched and desalted on the trapping column at a flow
rate of 6 mL/min with 0.1% TFA for 5 min. The trapping column was switched online with the separating column and peptides
were eluted with a multi-step binary gradient: linear gradient of buffer B (80% ACN, 0.1% formic acid) in buffer A (0.1% formic
acid) from 4% to 25% in 30 min, 25% to 50% in 10 min, 50% to 90% in 5 min and 10 min at 90% B. The column was reconditioned
to 4%B in 15min. The flow rate was 250 nL/min and the column temperature was set to 45C. The RSLC systemwas coupled online
via a Nano Spray Flex Ion Soure II (Thermo Fisher Scientific) to an LTQ-Orbitrap Velos mass spectrometer. Metal-coated fused-silica
emitters (SilicaTip, 10 mm i.d., NewObjectives) and a voltage of 1.3 kV were used for the electrospray. Overview scans were acquired
at a resolution of 60k in a mass range of m/z 300-1600 in the orbitrap analyzer and stored in profile mode. The top 10 most intensive
ions of charges two or three and a minimum intensity of 2000 counts were selected for CID fragmentation with a normalized collision
energy of 38.0, an activation time of 10 ms and an activation Q of 0.250 in the LTQ. Fragment ion mass spectra were recorded in the
LTQ at normal scan rate and stored as centroid m/z value and intensity pairs. Active exclusion was activated so that ions fragmentede4 Cell Reports 27, 2859–2870.e1–e6, June 4, 2019
once were excluded from further fragmentation for 70 s within a mass window of 10 ppm of the specific m/z value. Raw data were
processed using Proteome discoverer (Thermo Fisher Scientific) and murine uniprot/swissprot data bases containing common con-
taminants. Proteins were stated identified by a false discovery rate of 0.01 on protein and peptide level and quantified by extracted
ion chromatograms of all peptides.
MK2 interaction profiling by label-free mass-spectrometry
Per sample 3 to 4 confluent 15 cm dishes of the corresponding MK2 MEFs were either mock-treated (DMSO), pre-treated with the
MK2 inhibitor PF3644022 (10mM, Sigma) for 60 minutes or stimulated with Anisomycin (1mg/ml, Sigma) for 30 minutes before lysis.
Approximately 5mg of lysate was administered toMK2-immunoprecpitations using an agaroseMK2-Trap binding resin (Chromotek).
Beads were eluted in 2x Laemmli buffer and the resulting supernatants were loaded onto a 4%–12% NuPAGE Bis-Tris Gel (Novex,
Thermo Fisher Scientific). Gels were then fixed and stained using the colloidal blue staining kit (Life Technologies/Invitrogen). Gel
lanes were sliced into five pieces and proteins were digested in-gel using standard methods (Jensen et al., 1999). Peptides were re-
constituted in 5% CAN 0.1% TFA and analyzed with an Easy-nLC 1200 system (Thermo Scientific) connected to a Fusion Lumos
Orbitrap mass spectrometer (Thermo Scientific) through a nanoelectrospray ion source. Peptides were separated on a 15 cm
(75 mm inner diameter) in-house column packed with 1.9 mm reversed-phase C18 beads (Reprosil-Pur AQ, Dr. Maisch), with
45 min gradients. Spray voltage was set to 2kV, capillary temperature to 275C and RF level to 30%. A full scan was performed
at a resolution of 60,000, with a scan range of 350-1400 m/z, a maximum injection time of 20 ms and with an AGC target of
500,000. Precursors were isolated with a width of 1.3 m/z and precursor fragmentation was accomplished using higher collision
dissociation (HCD). Only precursors with charge state 2-5 were considered. MS/MS spectra were acquired in the Orbitrap, and set-
tings included a loop count of 7, a maximum injection time of 118 ms and a resolution of 60,000. Raw MS data were analyzed using
MaxQuant software (version 1.6.0.17). Proteins were identified with parameters previously described (Bekker-Jensen et al., 2017)
and quantified using the LFQ algorithm integrated in MaxQuant (Cox et al., 2014). Match between runs function was used. Data anal-
ysis was performed using Perseus software (Tyanova et al., 2016). Missing values were imputed in all samples using Perseus default
settings. Volcano plots were generated by plotting the –log10 transformed FDR-adjusted p values derived from a two-sided t test
versus log2 transformed fold changed. Significancewas determined based on a hyperbolic curve threshold of s0 = 0.1 using Perseus.
Migration Assay
Fibroblast migration was analyzed by a fluorescence-based scratch wound-healing assay as described previously (Menon et al.,
2009).
WST-1 Assay
Cell viability assays using WST-1 (water soluble tetrazolium, Roche # 11 644 807 001) were performed as described before (Tiedje
et al., 2016).
RNA extraction and qPCR
Total RNA from stimulated cells was extracted using Trizol (Thermo Fisher Scientific/Invitrogen) according to the instructions. 500 ng
RNA were then reverse transcribed to cDNA using random hexameric primers and Reverse Transcriptase (Thermo Fisher Scientific)
in the presence of RNase inhibitors. Quantitative PCRs (qPCRs) were performed on One Step-Plus real-time PCR systems (Applied
Biosystems/Thermo Fisher Scientific) using a 2x SYBR Green no ROX qPCR mix (Bioline) in a two-step cycling program. The se-
quences of qPCR primer are listed in Table S2.
Microscopy
Cells were seeded on coverslips and transfected the next day using FuGENE6 (Promega) according to standard settings. The
following day, cells were treated and immediately fixed with 4% PFA for 15 minutes at room temperature after washing twice with
1x PBS. Afterward, cells on coverslips were washed three times with 1x PBS before dipping them in MilliQ water and drying
them. After complete drying coverslips were mounted on a glass slide in 2.5ml DAPI-containing Vector Shield (Vector Laboratories)
mountingmedium and fixed on the slide to avoid dissolution. Glass slides were then kept at20C until use. Pictures were taken on a
Leica DM4 B device using the LasX Software (Leica Microsystems).
Bioinformatic analyses
The indicated datasets were analyzed using theGalaxy Suite (usegalaxy.org) (Afgan et al., 2016). In brief, raw readswere downloaded
from the GEO repository, demultiplexed and converted to the FASTQ format and groomed using ‘‘FASTQ Groomer‘‘. After adapter-
and quality-trimming using ‘‘Trim Galore!,’’ the reads were mapped against human hg19 or murine mm10 using ‘‘Bowtie2‘‘. Aligned
reads were then visualized in the Integrative Genomics Viewer (IGV) (Robinson et al., 2011; Thorvaldsdo´ttir et al., 2013).Cell Reports 27, 2859–2870.e1–e6, June 4, 2019 e5
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed with GraphPad PRISM 8 and in case of mass-spectrometry results with MaxQuant (version
1.6.0.17). Quantification of band intensities were carried out with the open source software ImageJ (version 1.50i). The number of
biological replicates that were analyzed and the statistical tests are given in the corresponding figure legends. If not indicated
differently, values are presented as mean ± SD (standard deviation). Significant differences (p values) are marked with: * % 0,05,
**% 0,01, ***% 0,001, ****% 0,0001.
DATA AND SOFTWARE AVAILABILITY
Nucleotide sequence data reported are available in the Third Party Annotation Section of the DDBJ/ENA/GenBank databases under
the accession number TPA: BK010697.e6 Cell Reports 27, 2859–2870.e1–e6, June 4, 2019
